申请人:Max-Delbrück-Centrum für Molekulare Medizin (MDC)
公开号:EP2208720A1
公开(公告)日:2010-07-21
The present invention provides compounds (n-3 PUFA derivatives) of formula (I):
that modulate conditions associated with cardiac damage, especially cardiac arrhythmias.